BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea of the Federal Food, Drug, and Cosmetic Act (FDCA).* BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides FDA Removes 12 Peptides from 503A Category 2 Newtropin